Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 10 January, 2012

GlaxoSmithKline PLC

Director/PDMR Shareholding - Replacement

RNS Number : 3416V
GlaxoSmithKline PLC
10 January 2012
 



This announcement replaces the original announcement released on 3 January 2012 at 17.30 (RNS No: 9377U).

 

Due to an administrative error the change in one of the Non-Executive Director's interests in the American Depositary Shares (ADSs) of GlaxoSmithKline plc indicated with an asterisk (*) below, was incorrectly stated in the announcement made on 3 January 2012.

 

Save as disclosed above, all other details remain unchanged. The full amended text is shown below.

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the directors' interests in the Ordinary shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

 

On 30 December 2011, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depositary Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2011:

 

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award- Annual Dividend Reinvestment

 

Non-Executive Director

No. of Ordinary Shares

Average Price (£)

No. of ADSs

Average Price ($)

Sir Christopher Gent

        3,072.732

14.70



Prof Sir Roy Anderson

       408.069

14.70



Dr Stephanie Burns



361.105

45.53

Ms Stacey Cartwright

3.865

14.70



Mr Lawrence Culp



1,133.685

45.53

Sir Crispin Davis

2,536.065

14.70



Ms Judy Lewent



1.998*

45.53

Sir Deryck Maughan



1,033.536

45.53

Mr James Murdoch

474.157

14.70



Dr Daniel Podolsky



623.023

45.53

Mr Tom de Swaan

612.754

14.70



Sir Robert Wilson

710.997

14.70



 

The Company and the Non-Executive Directors were informed of these allocations on

3 January 2012.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

10 January 2012

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAPFEFAFAEFF

a d v e r t i s e m e n t